8 months in and amylin is still the thing I get wrong
Check-in as promised in the title: 8 months in and amylin is still the thing I get wrong. 8 months. Those are measured, not estimated, and not rounded up in my favour. Kept a log purely because so few people are logging this one. It is one person and it is not data. Asked a question here that turned out to be based…
Not convinced. Amylin signalling is not a GLP-1 pathway and the mechanism you are proposing conflates them.
Careful — that is a dosing intuition carried over from another board and there is no basis for it here.
Careful — that is a dosing intuition carried over from another board and there is no basis for it here.
This is the distinction that keeps this board honest — different axis, not a stronger version of the same one.
REDEFINE is the combination programme
Independent purity data on this compound is sparse compared with the older molecules, simply because far fewer members have paid for testing. Sparse data means wide uncertainty, not a verdict.
Not convinced.
hedda_aguirre is right that the evidence base here is thin. Conclusions should be held loosely.